Philanthropy, Virtue, and Democratic Legitimacy: John Stuart Mill in Light of Theodore M. Lechterman’s Critique
Philanthropia · 2026-07-29 · 2 (2) · 97
DOI: 10.70902/wave1t72 ↗At a glance
Journal article in Philanthropia, published online on 2026-07-29. Written by Fernando Rodríguez Fernández. 12 references.
Abstract (original language)
This article examines two normative approaches to philanthropy within the liberal tradition: John Stuart Mill’s conception of benevolence and Theodore M. Lechterman’s democratic objection. First, it reconstructs Mill’s defense of benevolence as a dimension of moral character, linked to the cultivation of individuality and social sentiments and human progress. Second, it analyzes the contemporary critique of large-scale philanthropy as private power capable of eroding civic equality and democratic sovereignty. The article does not presuppose a full reconciliation between the two thinkers but rather explores whether certain elements of Millian ethics could be reinterpreted under contemporary democratic conditions in light of Lechterman’s thought. Ultimately, it proposes an understanding of philanthropy not as an absolute virtue, but as a conditional civic virtue, morally valuable in its motivation, while normatively legitimate when it respects the primacy of justice, public deliberation, and non-domination.
Cite
APA
Fernández, F. R. (2026). Philanthropy, Virtue, and Democratic Legitimacy: John Stuart Mill in Light of Theodore M. Lechterman’s Critique. Philanthropia, 2(2), 97. https://doi.org/10.70902/wave1t72
Vancouver
Fernández FR. Philanthropy, Virtue, and Democratic Legitimacy: John Stuart Mill in Light of Theodore M. Lechterman’s Critique. Philanthropia. 2026;2(2):97. doi:10.70902/wave1t72
BibTeX
@article{Fernndez2026,
author = {Fernández, Fernando Rodríguez},
title = {Philanthropy, Virtue, and Democratic Legitimacy: John Stuart Mill in Light of Theodore M. Lechterman’s Critique},
journal = {Philanthropia},
year = {2026},
volume = {2},
number = {2},
pages = {97},
doi = {10.70902/wave1t72}
}
EUVIMED